Request for Covid-19 Impact Assessment of this Report
The United States Nonerosive Reflux Disease Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Nonerosive Reflux Disease Treatment market, reaching US$ million by the year 2028. As for the Europe Nonerosive Reflux Disease Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Nonerosive Reflux Disease Treatment players cover AstraZeneca, Eisai, GlaxoSmithKline, and Takeda Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Nonerosive Reflux Disease Treatment market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Proton pump inhibitors
H2 Receptor Antagonists
Antacids
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Eisai
GlaxoSmithKline
Takeda Pharmaceutical
Johnson & Johnson
Daewoong Pharmaceutical
Ironwood Pharmaceuticals
SRS Pharmaceuticals
SFJ Pharmaceuticals Group
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nonerosive Reflux Disease Treatment Market Size 2017-2028
2.1.2 Nonerosive Reflux Disease Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Nonerosive Reflux Disease Treatment Segment by Type
2.2.1 Proton pump inhibitors
2.2.2 H2 Receptor Antagonists
2.2.3 Antacids
2.2.4 Others
2.3 Nonerosive Reflux Disease Treatment Market Size by Type
2.3.1 Nonerosive Reflux Disease Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Nonerosive Reflux Disease Treatment Market Size Market Share by Type (2017-2022)
2.4 Nonerosive Reflux Disease Treatment Segment by Application
2.4.1 Retail Pharmacies
2.4.2 Hospital Pharmacies
2.4.3 Online Pharmacies
2.5 Nonerosive Reflux Disease Treatment Market Size by Application
2.5.1 Nonerosive Reflux Disease Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Nonerosive Reflux Disease Treatment Market Size Market Share by Application (2017-2022)
3 Nonerosive Reflux Disease Treatment Market Size by Player
3.1 Nonerosive Reflux Disease Treatment Market Size Market Share by Players
3.1.1 Global Nonerosive Reflux Disease Treatment Revenue by Players (2020-2022)
3.1.2 Global Nonerosive Reflux Disease Treatment Revenue Market Share by Players (2020-2022)
3.2 Global Nonerosive Reflux Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nonerosive Reflux Disease Treatment by Regions
4.1 Nonerosive Reflux Disease Treatment Market Size by Regions (2017-2022)
4.2 Americas Nonerosive Reflux Disease Treatment Market Size Growth (2017-2022)
4.3 APAC Nonerosive Reflux Disease Treatment Market Size Growth (2017-2022)
4.4 Europe Nonerosive Reflux Disease Treatment Market Size Growth (2017-2022)
4.5 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Growth (2017-2022)
5 Americas
5.1 Americas Nonerosive Reflux Disease Treatment Market Size by Country (2017-2022)
5.2 Americas Nonerosive Reflux Disease Treatment Market Size by Type (2017-2022)
5.3 Americas Nonerosive Reflux Disease Treatment Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nonerosive Reflux Disease Treatment Market Size by Region (2017-2022)
6.2 APAC Nonerosive Reflux Disease Treatment Market Size by Type (2017-2022)
6.3 APAC Nonerosive Reflux Disease Treatment Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nonerosive Reflux Disease Treatment by Country (2017-2022)
7.2 Europe Nonerosive Reflux Disease Treatment Market Size by Type (2017-2022)
7.3 Europe Nonerosive Reflux Disease Treatment Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nonerosive Reflux Disease Treatment by Region (2017-2022)
8.2 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2017-2022)
8.3 Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Nonerosive Reflux Disease Treatment Market Forecast
10.1 Global Nonerosive Reflux Disease Treatment Forecast by Regions (2023-2028)
10.1.1 Global Nonerosive Reflux Disease Treatment Forecast by Regions (2023-2028)
10.1.2 Americas Nonerosive Reflux Disease Treatment Forecast
10.1.3 APAC Nonerosive Reflux Disease Treatment Forecast
10.1.4 Europe Nonerosive Reflux Disease Treatment Forecast
10.1.5 Middle East & Africa Nonerosive Reflux Disease Treatment Forecast
10.2 Americas Nonerosive Reflux Disease Treatment Forecast by Country (2023-2028)
10.2.1 United States Nonerosive Reflux Disease Treatment Market Forecast
10.2.2 Canada Nonerosive Reflux Disease Treatment Market Forecast
10.2.3 Mexico Nonerosive Reflux Disease Treatment Market Forecast
10.2.4 Brazil Nonerosive Reflux Disease Treatment Market Forecast
10.3 APAC Nonerosive Reflux Disease Treatment Forecast by Region (2023-2028)
10.3.1 China Nonerosive Reflux Disease Treatment Market Forecast
10.3.2 Japan Nonerosive Reflux Disease Treatment Market Forecast
10.3.3 Korea Nonerosive Reflux Disease Treatment Market Forecast
10.3.4 Southeast Asia Nonerosive Reflux Disease Treatment Market Forecast
10.3.5 India Nonerosive Reflux Disease Treatment Market Forecast
10.3.6 Australia Nonerosive Reflux Disease Treatment Market Forecast
10.4 Europe Nonerosive Reflux Disease Treatment Forecast by Country (2023-2028)
10.4.1 Germany Nonerosive Reflux Disease Treatment Market Forecast
10.4.2 France Nonerosive Reflux Disease Treatment Market Forecast
10.4.3 UK Nonerosive Reflux Disease Treatment Market Forecast
10.4.4 Italy Nonerosive Reflux Disease Treatment Market Forecast
10.4.5 Russia Nonerosive Reflux Disease Treatment Market Forecast
10.5 Middle East & Africa Nonerosive Reflux Disease Treatment Forecast by Region (2023-2028)
10.5.1 Egypt Nonerosive Reflux Disease Treatment Market Forecast
10.5.2 South Africa Nonerosive Reflux Disease Treatment Market Forecast
10.5.3 Israel Nonerosive Reflux Disease Treatment Market Forecast
10.5.4 Turkey Nonerosive Reflux Disease Treatment Market Forecast
10.5.5 GCC Countries Nonerosive Reflux Disease Treatment Market Forecast
10.6 Global Nonerosive Reflux Disease Treatment Forecast by Type (2023-2028)
10.7 Global Nonerosive Reflux Disease Treatment Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Nonerosive Reflux Disease Treatment Product Offered
11.1.3 AstraZeneca Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Nonerosive Reflux Disease Treatment Product Offered
11.2.3 Eisai Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Eisai Main Business Overview
11.2.5 Eisai Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Nonerosive Reflux Disease Treatment Product Offered
11.3.3 GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Takeda Pharmaceutical
11.4.1 Takeda Pharmaceutical Company Information
11.4.2 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product Offered
11.4.3 Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Takeda Pharmaceutical Main Business Overview
11.4.5 Takeda Pharmaceutical Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Nonerosive Reflux Disease Treatment Product Offered
11.5.3 Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Daewoong Pharmaceutical
11.6.1 Daewoong Pharmaceutical Company Information
11.6.2 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product Offered
11.6.3 Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Daewoong Pharmaceutical Main Business Overview
11.6.5 Daewoong Pharmaceutical Latest Developments
11.7 Ironwood Pharmaceuticals
11.7.1 Ironwood Pharmaceuticals Company Information
11.7.2 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product Offered
11.7.3 Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Ironwood Pharmaceuticals Main Business Overview
11.7.5 Ironwood Pharmaceuticals Latest Developments
11.8 SRS Pharmaceuticals
11.8.1 SRS Pharmaceuticals Company Information
11.8.2 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product Offered
11.8.3 SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 SRS Pharmaceuticals Main Business Overview
11.8.5 SRS Pharmaceuticals Latest Developments
11.9 SFJ Pharmaceuticals Group
11.9.1 SFJ Pharmaceuticals Group Company Information
11.9.2 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product Offered
11.9.3 SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 SFJ Pharmaceuticals Group Main Business Overview
11.9.5 SFJ Pharmaceuticals Group Latest Developments
12 Research Findings and Conclusion
Table 1. Nonerosive Reflux Disease Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Proton pump inhibitors
Table 3. Major Players of H2 Receptor Antagonists
Table 4. Major Players of Antacids
Table 5. Major Players of Others
Table 6. Nonerosive Reflux Disease Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Nonerosive Reflux Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Nonerosive Reflux Disease Treatment Market Size Market Share by Type (2017-2022)
Table 9. Nonerosive Reflux Disease Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Nonerosive Reflux Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Nonerosive Reflux Disease Treatment Market Size Market Share by Application (2017-2022)
Table 12. Global Nonerosive Reflux Disease Treatment Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Player (2020-2022)
Table 14. Nonerosive Reflux Disease Treatment Key Players Head office and Products Offered
Table 15. Nonerosive Reflux Disease Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nonerosive Reflux Disease Treatment Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Nonerosive Reflux Disease Treatment Market Size Market Share by Regions (2017-2022)
Table 20. Americas Nonerosive Reflux Disease Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Nonerosive Reflux Disease Treatment Market Size Market Share by Country (2017-2022)
Table 22. Americas Nonerosive Reflux Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Nonerosive Reflux Disease Treatment Market Size Market Share by Type (2017-2022)
Table 24. Americas Nonerosive Reflux Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Nonerosive Reflux Disease Treatment Market Size Market Share by Application (2017-2022)
Table 26. APAC Nonerosive Reflux Disease Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Nonerosive Reflux Disease Treatment Market Size Market Share by Region (2017-2022)
Table 28. APAC Nonerosive Reflux Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Nonerosive Reflux Disease Treatment Market Size Market Share by Type (2017-2022)
Table 30. APAC Nonerosive Reflux Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Nonerosive Reflux Disease Treatment Market Size Market Share by Application (2017-2022)
Table 32. Europe Nonerosive Reflux Disease Treatment Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Nonerosive Reflux Disease Treatment Market Size Market Share by Country (2017-2022)
Table 34. Europe Nonerosive Reflux Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Nonerosive Reflux Disease Treatment Market Size Market Share by Type (2017-2022)
Table 36. Europe Nonerosive Reflux Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Nonerosive Reflux Disease Treatment Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Nonerosive Reflux Disease Treatment
Table 45. Key Market Challenges & Risks of Nonerosive Reflux Disease Treatment
Table 46. Key Industry Trends of Nonerosive Reflux Disease Treatment
Table 47. Global Nonerosive Reflux Disease Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Nonerosive Reflux Disease Treatment Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Nonerosive Reflux Disease Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Nonerosive Reflux Disease Treatment Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Nonerosive Reflux Disease Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Nonerosive Reflux Disease Treatment Market Size Market Share Forecast by Application (2023-2028)
Table 53. AstraZeneca Details, Company Type, Nonerosive Reflux Disease Treatment Area Served and Its Competitors
Table 54. AstraZeneca Nonerosive Reflux Disease Treatment Product Offered
Table 55. AstraZeneca Nonerosive Reflux Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. AstraZeneca Main Business
Table 57. AstraZeneca Latest Developments
Table 58. Eisai Details, Company Type, Nonerosive Reflux Disease Treatment Area Served and Its Competitors
Table 59. Eisai Nonerosive Reflux Disease Treatment Product Offered
Table 60. Eisai Main Business
Table 61. Eisai Nonerosive Reflux Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Eisai Latest Developments
Table 63. GlaxoSmithKline Details, Company Type, Nonerosive Reflux Disease Treatment Area Served and Its Competitors
Table 64. GlaxoSmithKline Nonerosive Reflux Disease Treatment Product Offered
Table 65. GlaxoSmithKline Main Business
Table 66. GlaxoSmithKline Nonerosive Reflux Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. GlaxoSmithKline Latest Developments
Table 68. Takeda Pharmaceutical Details, Company Type, Nonerosive Reflux Disease Treatment Area Served and Its Competitors
Table 69. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Product Offered
Table 70. Takeda Pharmaceutical Main Business
Table 71. Takeda Pharmaceutical Nonerosive Reflux Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Takeda Pharmaceutical Latest Developments
Table 73. Johnson & Johnson Details, Company Type, Nonerosive Reflux Disease Treatment Area Served and Its Competitors
Table 74. Johnson & Johnson Nonerosive Reflux Disease Treatment Product Offered
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Nonerosive Reflux Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Johnson & Johnson Latest Developments
Table 78. Daewoong Pharmaceutical Details, Company Type, Nonerosive Reflux Disease Treatment Area Served and Its Competitors
Table 79. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Product Offered
Table 80. Daewoong Pharmaceutical Main Business
Table 81. Daewoong Pharmaceutical Nonerosive Reflux Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Daewoong Pharmaceutical Latest Developments
Table 83. Ironwood Pharmaceuticals Details, Company Type, Nonerosive Reflux Disease Treatment Area Served and Its Competitors
Table 84. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Product Offered
Table 85. Ironwood Pharmaceuticals Main Business
Table 86. Ironwood Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Ironwood Pharmaceuticals Latest Developments
Table 88. SRS Pharmaceuticals Details, Company Type, Nonerosive Reflux Disease Treatment Area Served and Its Competitors
Table 89. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Product Offered
Table 90. SRS Pharmaceuticals Main Business
Table 91. SRS Pharmaceuticals Nonerosive Reflux Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. SRS Pharmaceuticals Latest Developments
Table 93. SFJ Pharmaceuticals Group Details, Company Type, Nonerosive Reflux Disease Treatment Area Served and Its Competitors
Table 94. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Product Offered
Table 95. SFJ Pharmaceuticals Group Main Business
Table 96. SFJ Pharmaceuticals Group Nonerosive Reflux Disease Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. SFJ Pharmaceuticals Group Latest Developments
List of Figures
Figure 1. Nonerosive Reflux Disease Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nonerosive Reflux Disease Treatment Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Nonerosive Reflux Disease Treatment Market Size Market Share by Type in 2021
Figure 7. Nonerosive Reflux Disease Treatment in Retail Pharmacies
Figure 8. Global Nonerosive Reflux Disease Treatment Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 9. Nonerosive Reflux Disease Treatment in Hospital Pharmacies
Figure 10. Global Nonerosive Reflux Disease Treatment Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 11. Nonerosive Reflux Disease Treatment in Online Pharmacies
Figure 12. Global Nonerosive Reflux Disease Treatment Market: Online Pharmacies (2017-2022) & ($ Millions)
Figure 13. Global Nonerosive Reflux Disease Treatment Market Size Market Share by Application in 2021
Figure 14. Global Nonerosive Reflux Disease Treatment Revenue Market Share by Player in 2021
Figure 15. Global Nonerosive Reflux Disease Treatment Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Nonerosive Reflux Disease Treatment Market Size 2017-2022 ($ Millions)
Figure 17. APAC Nonerosive Reflux Disease Treatment Market Size 2017-2022 ($ Millions)
Figure 18. Europe Nonerosive Reflux Disease Treatment Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size 2017-2022 ($ Millions)
Figure 20. Americas Nonerosive Reflux Disease Treatment Value Market Share by Country in 2021
Figure 21. Americas Nonerosive Reflux Disease Treatment Consumption Market Share by Type in 2021
Figure 22. Americas Nonerosive Reflux Disease Treatment Market Size Market Share by Application in 2021
Figure 23. United States Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Nonerosive Reflux Disease Treatment Market Size Market Share by Region in 2021
Figure 28. APAC Nonerosive Reflux Disease Treatment Market Size Market Share by Application in 2021
Figure 29. China Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Nonerosive Reflux Disease Treatment Market Size Market Share by Country in 2021
Figure 36. Europe Nonerosive Reflux Disease Treatment Market Size Market Share by Type in 2021
Figure 37. Europe Nonerosive Reflux Disease Treatment Market Size Market Share by Application in 2021
Figure 38. Germany Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size Market Share by Application in 2021
Figure 46. Egypt Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Nonerosive Reflux Disease Treatment Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 52. APAC Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 53. Europe Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 55. United States Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 56. Canada Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 59. China Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 60. Japan Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 61. Korea Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 63. India Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 64. Australia Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 65. Germany Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 66. France Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 67. UK Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 68. Italy Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 69. Russia Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 70. Spain Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 73. Israel Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Nonerosive Reflux Disease Treatment Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...